Science Explorer Interactive view Map
Company · Dayton · United States

Aurobindo Pharma (United States)

aurobindousa.comROR OpenAlex
Research works
120
▼ 15% vs 2013–17
Citations
3.7k
31.0 per fractional work
Top-10% rate
13.7%
record average 16.5%
Open access
32%
world 28%

Not ranked overall: Aurobindo Pharma (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 2.50× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 1.89× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 0.22× its world share, 0 worksImmunology and Micro…Chemistry: 6.43× its world share, 1 worksChemistryComputer Science: 0.92× its world share, 0 worksComputer ScienceEngineering: 0.15× its world share, 0 worksEngineeringEnvironmental Science: 0.45× its world share, 0 worksEnvironmental ScienceMaterials Science: 1.58× its world share, 0 worksMaterials SciencePhysics and Astronomy: 0.25× its world share, 0 worksPhysics and AstronomyMedicine: 2.17× its world share, 3 worksMedicineNursing: 4.58× its world share, 0 worksNursingSocial Sciences: 0.49× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Chemistry, 6.4×. Every wedge is a field page.

Which keywords describe research at Aurobindo Pharma (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Medicinal Chemistry, Drug Discovery, Cancer Therapy, Cancer, Anticancer Agents, Pharmacology, Synthesis and Pharmacokinetics.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Epidemiology8▲ 1.59×23 topics
  2. Cancer7▲ 4.3×19 topics
  3. Drug Discovery7▲ 14×10 topics
  4. Inflammation7▲ 2.4×22 topics
  5. Medicinal Chemistry7▲ 15×6 topics
  6. Cancer Therapy6▲ 8.1×16 topics
  7. Anticancer Agents5▲ 17×9 topics
  8. Synthesis5▲ 6.9×11 topics
  9. Pharmacology5▲ 12×8 topics
  10. Immune Response4▲ 5.9×9 topics
  11. Pharmacokinetics4▲ 13×2 topics
  12. Heterocyclic Compounds4▲ 22×3 topics
  13. Method Validation4▲ 42×2 topics
  14. Molecular Mechanisms4▲ 18×3 topics
  15. Antimicrobial Resistance4▲ 12×4 topics
  16. Liquid Chromatography4▲ 20×2 topics
  17. Regulation3▲ 4.7×5 topics
  18. Signal Transduction3▲ 12×2 topics
  19. Genetic Variation3▲ 8.0×3 topics
  20. Green Analytical Chemistry3▲ 27×2 topics
  21. Biological Evaluation3▲ 19×4 topics
  22. Clinical Guidelines3▲ 7.7×3 topics
  23. Molecular Docking3▲ 17×2 topics
  24. Pharmaceutical Analysis3▲ 78×1 topic
  25. Validation3▲ 24×1 topic
  26. Monoclonal Antibodies3▲ 16×3 topics
  27. Antibiotic Pharmacokinetics3▲ 50×1 topic
  28. Cell Signaling3▲ 6.8×2 topics
  29. Continuous Infusion3▲ 46×2 topics
  30. Critically Ill Patients3▲ 50×1 topic
  31. Chirality3▲ 14×2 topics
  32. Drug Development3▲ 15×4 topics
  33. Drug Resistance3▲ 6.9×5 topics
  34. Genetic Variants3▲ 10×3 topics
  35. Anticancer2▲ 11×7 topics
  36. Chiral Separation2▲ 17×1 topic
  37. Coumarins2▲ 35×2 topics
  38. Gas Chromatography2▲ 17×1 topic
  39. Transcriptional Regulation2▲ 8.2×5 topics
  40. Antiretroviral Therapy2▲ 8.7×4 topics

Which research topics does Aurobindo Pharma (United States) publish most on?

By volume in 2022–2025: SARS-CoV-2 and COVID-19 Research, Essential Oils and Antimicrobial Activity, Synthesis and biological activity and Viral gastroenteritis research and epidemiology.

SARS-CoV-2 and COVID-19 …0SARS-CoV-2 and COVID-19 Research: 0 fractional worksEssential Oils and Antim…0Essential Oils and Antimicrobial Activity: 0 fractional worksSynthesis and biological…0Synthesis and biological activity: 0 fractional worksViral gastroenteritis re…0Viral gastroenteritis research and epidemiology: 0 fractional worksAnimal Virus Infections Studies: 0 fractional worksLegal and Regulatory Analysis: 0 fractional worksNanoparticles: synthesis…0Nanoparticles: synthesis and applications: 0 fractional worksResearch on Leishmaniasis Studies: 0 fractional worksSynthesis and Biological Evaluation: 0 fractional worksAdvanced Neural Network …0Advanced Neural Network Applications: 0 fractional works
Infectious DiseasesFood ScienceOrganic ChemistryAnimal Science and Zoology4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 SARS-CoV-2 and COVID-19 Research Infectious Diseases 0 works
  2. 2 Essential Oils and Antimicrobial Activity Food Science 0 works
  3. 3 Synthesis and biological activity Organic Chemistry 0 works
  4. 4 Viral gastroenteritis research and epidemiology Infectious Diseases 0 works
  5. 5 Animal Virus Infections Studies Animal Science and Zoology 0 works
  6. 6 Legal and Regulatory Analysis Transportation 0 works
  7. 7 Nanoparticles: synthesis and applications Materials Chemistry 0 works
  8. 8 Research on Leishmaniasis Studies Public Health, Environmental and Occupational Health 0 works
  9. 9 Synthesis and Biological Evaluation Organic Chemistry 0 works
  10. 10 Advanced Neural Network Applications Computer Vision and Pattern Recognition 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available31.7%not open68.3%

World: 28% of research is openly available.

with international co-authors27.7%domestic only72.3%

World: 19% is written across borders.

How has Aurobindo Pharma (United States)'s research output changed?

Output in 2018–2022 was 15% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.